In last week’s column, I told you how the 2024 General Election (early voting has started) could lead to healthier, smarter, and longer lives for all of us (see: ...

However, Novavax's shares recently dropped by about 20% in one day after it announced a clinical setback. The biotech's stock ...

And FDA said that Boston Scientific has again issued new instructions for its Obsidio Conformable Embolic after 15 injuries ...

A vaccine against fentanyl—yes! Finally, a truly novel approach to SUDs is currently under development and hopefully will ...

In the post-Covid-19 era, transparent leadership at both the governmental and corporation levels is not just a strategic ...

A partial hold was placed on the trial after results showed variance between squamous and non-squamous NSCLC patient ...

The biotech industry is buzzing with exciting changes, and a lot of it is thanks to one company: Moderna. Known for its COVID ...

Karolinska Development AB (Nasdaq Stockholm: KDEV) announces that its portfolio company SVF Vaccines, has presented positive clinical safety and immunogenicity data from a clinical phase 1 study of ...

Thanks to mass immunization campaigns, by the year 2000, measles, once a common childhood illness with severe complications, ...

The biotechnology giant has not ruled out expanding its pipeline of treatments through acquisitions after a number of ...

On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...